Zimei Wu

Zimei Wu

School of Pharmacy, University of Auckland

Affiliated withUniversity of Auckland

Research Area

Biography

Dr Zimei Wu is an Associate Professor at the School of Pharmacy, The University of Auckland, New Zealand (NZ). She hold a MSc degree from China Pharmaceutical University and a PhD from University of Otago (NZ). In 1999, she came to School of Pharmacy, University of Otago as a visiting scholar where she later on commenced her PhD followed by postdoctoral research. In 2009, Dr Wu was appointed as a lecturer at School of Pharmacy, University of Auckland, where she teaches and researches in all aspects of pharmaceutical sciences. In the past 10 years she has focused on design and engineering of nano-vesicles such as liposomes, noisomes, and liposomes-exosome hybrids with biological functions to target disease hallmarks (receptors, transporters, low pH, redox potential), and understanding of cellular trafficking of nano-systems.

Dr Wu is the immediate Past President of NZ Chapter of Controlled Release Society (CRS), and serves on the Editorial Boards of Journal of Liposome Research and Pharmaceutical Development and Technology, Biomaterials Science etc, and has been a referee for more than 20 research journals.

JoVE Journal Publications

ArticleTotal : 1
Year
Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes
Publication title

Cited by 2

2020

Other Publications

Article
Year
Preparation, safety, pharmacokinetics, and pharmacodynamics of liposomes containing Brucea javanica oil.

AAPS PharmSciTech| PubMed ID: 20490956

2010
2010
2010
2011
2012
2012
2012
Advanced carrier systems in cosmetics and cosmeceuticals: a review.

Journal of cosmetic science| PubMed ID: 22682399

2012
2013
Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells.

Metabolomics : Official journal of the Metabolomic Society| PubMed ID: 24039617

2013
A study of microemulsions as prolonged-release injectables through in-situ phase transition.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 24316265

2014
2014
2014
2014
2014
2015
2016
2015
2015
Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 25701612

2015
2015
Pharmacokinetics and tissue distribution of Aucubin, Ajugol and Catalpol in rats using a validated simultaneous LC-ESI-MS/MS assay.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences| PubMed ID: 26342167

2015
Supercritical Fluid Technologies to Fabricate Proliposomes.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques| PubMed ID: 26670368

2015
2016
2016
2016
2016
Improving drug retention in liposomes by aging with the aid of glucose.

International journal of pharmaceutics| PubMed ID: 27021465

2016
2016
2016
Integrated scientific data bases review on asulacrine and associated toxicity.

Critical reviews in oncology/hematology| PubMed ID: 27321375

2016
2016
2017
2017
2017
Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 28666726

2017
2017
2019
2018
2018
2018
2018
2018
2018
2018
Advances in rectal drug delivery systems.

Pharmaceutical development and technology| PubMed ID: 29888992

2018
2018
The effect of DSPE-PEG, cholesterol and drug incorporated in bilayer on the formation of discoidal micelles.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences| PubMed ID: 30236551

2018
2018
2018
2019
2019
2019
Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 31096017

2019
2019
Drug stability testing and formulation strategies.

Pharmaceutical development and technology| PubMed ID: 31284808

2018
2019
Exploration of the antibiotic potentiating activity of indolglyoxylpolyamines.

European journal of medicinal chemistry| PubMed ID: 31550659

2019
2020
2020
Size-adaptable and ligand (biotin)-sheddable nanocarriers equipped with avidin scavenging technology for deep tumor penetration and reduced toxicity.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 31978442

2020